385 related articles for article (PubMed ID: 27689785)
1. Methionine sulfoximine supplementation enhances productivity in GS-CHOK1SV cell lines through glutathione biosynthesis.
Feary M; Racher AJ; Young RJ; Smales CM
Biotechnol Prog; 2017 Jan; 33(1):17-25. PubMed ID: 27689785
[TBL] [Abstract][Full Text] [Related]
2. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells.
Fan L; Kadura I; Krebs LE; Hatfield CC; Shaw MM; Frye CC
Biotechnol Bioeng; 2012 Apr; 109(4):1007-15. PubMed ID: 22068567
[TBL] [Abstract][Full Text] [Related]
3. Development of transfection and high-producer screening protocols for the CHOK1SV cell system.
de la Cruz Edmonds MC; Tellers M; Chan C; Salmon P; Robinson DK; Markusen J
Mol Biotechnol; 2006 Oct; 34(2):179-90. PubMed ID: 17172663
[TBL] [Abstract][Full Text] [Related]
4. Development of a highly-efficient CHO cell line generation system with engineered SV40E promoter.
Fan L; Kadura I; Krebs LE; Larson JL; Bowden DM; Frye CC
J Biotechnol; 2013 Dec; 168(4):652-8. PubMed ID: 23994266
[TBL] [Abstract][Full Text] [Related]
5. Attenuated glutamine synthetase as a selection marker in CHO cells to efficiently isolate highly productive stable cells for the production of antibodies and other biologics.
Lin PC; Chan KF; Kiess IA; Tan J; Shahreel W; Wong SY; Song Z
MAbs; 2019 Jul; 11(5):965-976. PubMed ID: 31043114
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characterization of glutamine synthetase-mediated selection for the establishment of recombinant CHO cells producing monoclonal antibodies.
Noh SM; Shin S; Lee GM
Sci Rep; 2018 Mar; 8(1):5361. PubMed ID: 29599455
[TBL] [Abstract][Full Text] [Related]
7. Limitations to the development of recombinant human embryonic kidney 293E cells using glutamine synthetase-mediated gene amplification: Methionine sulfoximine resistance.
Yu DY; Noh SM; Lee GM
J Biotechnol; 2016 Aug; 231():136-140. PubMed ID: 27288593
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term effects on mAb-producing CHO cell lines after cryopreservation.
Subramanian J; Aulakh RPS; Grewal PS; Sanford M; Pynn AFJ; Yuk IH
Biotechnol Prog; 2018 Mar; 34(2):463-477. PubMed ID: 29314708
[TBL] [Abstract][Full Text] [Related]
9. Limitations to the development of humanized antibody producing Chinese hamster ovary cells using glutamine synthetase-mediated gene amplification.
Jun SC; Kim MS; Hong HJ; Lee GM
Biotechnol Prog; 2006; 22(3):770-80. PubMed ID: 16739961
[TBL] [Abstract][Full Text] [Related]
10. Supplementation of Nucleosides During Selection can Reduce Sequence Variant Levels in CHO Cells Using GS/MSX Selection System.
Tang D; Lam C; Louie S; Hoi KH; Shaw D; Yim M; Snedecor B; Misaghi S
Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 28745430
[TBL] [Abstract][Full Text] [Related]
11. Reduction of ammonia and lactate through the coupling of glutamine synthetase selection and downregulation of lactate dehydrogenase-A in CHO cells.
Noh SM; Park JH; Lim MS; Kim JW; Lee GM
Appl Microbiol Biotechnol; 2017 Feb; 101(3):1035-1045. PubMed ID: 27704181
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of glutamine synthetase selection marker improves product titer and reduces glutamine overflow in Chinese hamster ovary cells.
Sacco SA; Tuckowski AM; Trenary I; Kraft L; Betenbaugh MJ; Young JD; Smith KD
Biotechnol Bioeng; 2022 Jul; 119(7):1712-1727. PubMed ID: 35312045
[TBL] [Abstract][Full Text] [Related]
13. CHOK1SV GS-KO SSI expression system: A combination of the Fer1L4 locus and glutamine synthetase selection.
Feary M; Moffat MA; Casperson GF; Allen MJ; Young RJ
Biotechnol Prog; 2021 Jul; 37(4):e3137. PubMed ID: 33609084
[TBL] [Abstract][Full Text] [Related]
14. Superfluous glutamine synthetase activity in Chinese Hamster Ovary cells selected under glutamine limitation is growth limiting in glutamine-replete conditions and can be inhibited by serine.
Maralingannavar V; Parmar D; Panchagnula V; Gadgil M
Biotechnol Prog; 2019 Sep; 35(5):e2856. PubMed ID: 31148368
[TBL] [Abstract][Full Text] [Related]
15. A high cell density transient transfection system for therapeutic protein expression based on a CHO GS-knockout cell line: process development and product quality assessment.
Rajendra Y; Hougland MD; Alam R; Morehead TA; Barnard GC
Biotechnol Bioeng; 2015 May; 112(5):977-86. PubMed ID: 25502369
[TBL] [Abstract][Full Text] [Related]
16. Glutamine synthetase gene knockout-human embryonic kidney 293E cells for stable production of monoclonal antibodies.
Yu DY; Lee SY; Lee GM
Biotechnol Bioeng; 2018 May; 115(5):1367-1372. PubMed ID: 29359789
[TBL] [Abstract][Full Text] [Related]
17. Reducing recombinant protein expression during CHO pool selection enhances frequency of high-producing cells.
Poulain A; Mullick A; Massie B; Durocher Y
J Biotechnol; 2019 Apr; 296():32-41. PubMed ID: 30885656
[TBL] [Abstract][Full Text] [Related]
18. Enhancing CHO cell productivity through a dual selection system using Aspg and Gs in glutamine free medium.
Ha TK; Òdena A; Karottki KJC; Kim CL; Hefzi H; Lee GM; Faustrup Kildegaard H; Nielsen LK; Grav LM; Lewis NE
Biotechnol Bioeng; 2023 Apr; 120(4):1159-1166. PubMed ID: 36562657
[TBL] [Abstract][Full Text] [Related]
19. Biological insights into the expression of translation initiation factors from recombinant CHOK1SV cell lines and their relationship to enhanced productivity.
Mead EJ; Masterton RJ; Feary M; Obrezanova O; Zhang L; Young R; Smales CM
Biochem J; 2015 Dec; 472(3):261-73. PubMed ID: 26420881
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker.
Bebbington CR; Renner G; Thomson S; King D; Abrams D; Yarranton GT
Biotechnology (N Y); 1992 Feb; 10(2):169-75. PubMed ID: 1369477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
